Skip to main content
NCBI home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2007 Dec 28;8(4):289–297. doi: 10.1208/pt0804116

Influence of selected formulation variables on the preparation of enzyme-entrapped eudragit S100 microspheres

Manju Rawat 1, Shailendra Saraf 1, Swarnlata Saraf 1,✉
PMCID: PMC2750702  PMID: 18181537

Abstract

The aim of this work is to study the influence of formulation parameters in the preparation of sustained release enzyme-loaded Eudragit S100 microspheres by emulsion solvent diffusion technique. A 32 full factorial experiment was designed to study the effects of the amount of solvent (dichloromethane) and stabilizers (Tween 20, 40, or 80) on the drug content and microsphere size. The results of analysis of variance test for both effects indicated that the test is significant. The effect of amount of stabilizer was found to be higher on both responses (SSY1=45.60; SSY2=737.93), whereas solvent concentration comparatively produced significant effect on the size of microspheres (SSY1=0.81; SSY2=358.83). Scanning electron microscopy of microspheres with maximum drug content (2.5 mL dichloromethane and 0.1 mL Tween 80) demonstrated smooth surface spherical particles with mean diameter of 56.83±2.88 µm. The effect of formulation variables on the integrity of enzyme was confirmed by in vitro proteolytic activity. The enteric nature of microspheres was evaluated and results demonstrated ∼6% to 7% release of enzyme in acidic medium. The release of enzyme from microspheres followed Higuchi kinetics. In phosphate buffer, microspheres showed an initial burst release of 20.34%±2.35% in 1 hour with additional 58.79%±4.32% release in the next 5 hours. Three dimensional response graphs were presented to visualize the effect of independent variables on the chosen response. Thus, Eudragit S100 microspheres can be successfully prepared for oral delivery of enzymes with desirable characters in terms of maximum loading and diffusion release pattern.

Keywords: Enzyme delivery, factorial design, Tween 80, microspheres, 3D response graphs

Full Text

The Full Text of this article is available as a PDF (391.7 KB).

References

  • 1.Gombotz WR, Pettit DK. Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem. 1995;6:332–351. doi: 10.1021/bc00034a002. [DOI] [PubMed] [Google Scholar]
  • 2.Benita S. Microencapsulation: Methods and Industrial applications. New York, NY: Marcel Dekkar; 1996. [Google Scholar]
  • 3.Kim BK, Hwang SJ, Park JB, Park HJ. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul. 2002;19:811–882. doi: 10.1080/0265204021000022770. [DOI] [PubMed] [Google Scholar]
  • 4.Dashora K, Saraf S, Saraf S. In-vitro studies of tizanidine controlled release microcapsullar matrices. Pak J Pharm Sci. 2006;19:177–181. [PubMed] [Google Scholar]
  • 5.Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. In vitro drug release behaviour of D, L-lactide / glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by novel spontaneous emulsification solvent diffusion method. J Pharm Sci. 1994;83:727–732. doi: 10.1002/jps.2600830527. [DOI] [PubMed] [Google Scholar]
  • 6.Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparation of biodegradable nano-spheres of water soluble and insoluble drugs with D, L-lactide / glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour. J Control Release. 1993;25:89–98. doi: 10.1016/0168-3659(93)90097-O. [DOI] [Google Scholar]
  • 7.Florence AT, Whitehill D. The formulation and stability of multiple emulsions. Int J Pharm. 1982;11:277–308. doi: 10.1016/0378-5173(82)90080-1. [DOI] [Google Scholar]
  • 8.Fong JW, inventor. Fong JW, assignee. Process for preparation of microspheres. US Patent 4 933 105. June 12, 1980.
  • 9.Carrio A, Schwach G, Coudane J, Vert M. Preparation and degradation of surfactant free PLAGA microspheres. J Control Release. 1995;37:113–121. doi: 10.1016/0168-3659(95)00070-O. [DOI] [Google Scholar]
  • 10.Minardi F, Belpoggi F, Soffritti M, et al. Results of long-term carcinogenicity bioassay on vinyl acetate monomer in sprague-dawley rats. Ann N Y Acad Sci. 2002;982:106–122. doi: 10.1111/j.1749-6632.2002.tb04927.x. [DOI] [PubMed] [Google Scholar]
  • 11.Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with serrapeptase: a randomized double blind controlled trial. Singapore Med J. 1989;30:48–54. [PubMed] [Google Scholar]
  • 12.Majima Y, Hirata K, Takeuchi M, et al. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am Rev Respit Dis. 1990;141:79–83. doi: 10.1164/ajrccm/141.1.79. [DOI] [PubMed] [Google Scholar]
  • 13.Sherry S, Fletcher AP. Proteolytic enzymes: a therapeutic evaluation. Clin Pharmacol Ther. 1960;1:202–206. [Google Scholar]
  • 14.Miyata K. Intestinal absorption ofSerratia peptidase. J Appl Biochem. 1980;2:111–116. [Google Scholar]
  • 15.Rawat M, Singh S, Saraf S, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull. 2006;29:1790–1798. doi: 10.1248/bpb.29.1790. [DOI] [PubMed] [Google Scholar]
  • 16.Jain D, Panda AK, Majumdar DK. Eudragit S100 entrapped insulin microspheres for oral delivery.AAPS PharmSciTech. 2005;6:E16. [DOI] [PMC free article] [PubMed]
  • 17.Dubey RR, Parikh RH. Two stage optimization process for formulation of chitosan microspheres.AAPS PharmSciTech. 2004;5:E5. [DOI] [PMC free article] [PubMed]
  • 18.Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int J Pharm. 2005;306:24–40. doi: 10.1016/j.ijpharm.2005.07.026. [DOI] [PubMed] [Google Scholar]
  • 19.Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh Y. Preparation of controlled release microspheres of ibuprofen with acrylic polymers by a novel quassi-emulsion solvent diffusion method. J Pharm Sci. 1989;78:68–72. doi: 10.1002/jps.2600780118. [DOI] [PubMed] [Google Scholar]
  • 20.Dashora K, Saraf S, Saraf S. Effect of processing variables on micro particulate system of aceclofenac. Pak J Pharm Sci. 2006;19:6–10. [PubMed] [Google Scholar]
  • 21.Saudagar RB, Rawat M, Singh D, Saraf S, Saraf S. Development and validation of derivative spectrophotometric method for determination of serratiopeptidase in pharmaceutical formulation.Oriental J Chem. 2007;In press.
  • 22.Committee on Institute of Medicine . Food and Chemical Codex. Washington, DC: National Academic Press; 2003. [Google Scholar]
  • 23.Sah H. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effect of its extraction rate on the characteristics of PLGA microparticles. J Control Release. 1997;47:233–245. doi: 10.1016/S0168-3659(97)01647-7. [DOI] [Google Scholar]
  • 24.Yamakawa I, Tsushima Y, Machida R, Watanabe S. Preparation of neurotensin analogue containing poly (dl-lactic acid) microspheres formed by oil-in-water solvent evaporation. J Pharm Sci. 1992;81:899–903. doi: 10.1002/jps.2600810912. [DOI] [PubMed] [Google Scholar]
  • 25.Kibbe AH. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC: Pharmaceutical Press; 2000. [Google Scholar]
  • 26.Salamone PR, Wodzinski RJ. Production, purification and characterization of a 50-kDa extracellular metalloprotease fromSerratia marcescens. Appl Microbiol Biotechnol. 1997;48:317–324. doi: 10.1007/s002530051056. [DOI] [PubMed] [Google Scholar]
  • 27.Jalil R, Nixon JR. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul. 1990;7:297–325. doi: 10.3109/02652049009021842. [DOI] [PubMed] [Google Scholar]
  • 28.Mendenhall W, Sincich T. Multiple Regression: A Second Course in Business Statistics: Regression Analysis. San Francisco, CA: Dellen Publishing; 1989. [Google Scholar]
  • 29.Cheu RRL, Chen PF, Chen W, Lin WJ. In vitro modified release of acyclovir from ethyl cellulose microspheres. J Microencapsul. 2001;18:559–565. doi: 10.1080/02652040010018155. [DOI] [PubMed] [Google Scholar]
  • 30.Gao Y, Cui FD, Guan Y, et al. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J Pharm. 2006;318:62–69. doi: 10.1016/j.ijpharm.2006.03.018. [DOI] [PubMed] [Google Scholar]
  • 31.Zhang JX, Zhu KJ. An improvement of double emulsion technique for preparing bovine serum albumin loaded PLGA microspheres. J Microencapsul. 2004;21:775–785. doi: 10.1080/02652040400008465. [DOI] [PubMed] [Google Scholar]
  • 32.Blanchette J, Park K, Peppas NA. Oral administration of chemotherapeutic agents using complexation hydrogels. In: McKittrick J, Aizenberg J, Orme C, Vekilov P, editors. Biological and Biomimetic Materials — Properties to Function. Pittsburgh, PA: MRS; 2002. pp. 218–222. [Google Scholar]
  • 33.Gibaldi M, Perrier D. Pharmacokinetics. New York, NY: Marcel Dekker; 1982. [Google Scholar]
  • 34.Shargel L, Yu A. Applied Biopharmaceutics and Pharmacokinetics. London, UK: Prentice Hall International, Inc; 1999. [Google Scholar]
  • 35.Lee TWY, Robinson JR. Controlled-release drug-delivery systems. In: Gennaro AR, editor. Remington: The Science and Practice of Pharmacy. vol. 1. 20th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000. pp. 910–911. [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES